Nanotherapy for Neural Retinal Regeneration
Advanced Science · 2025
DOI: 10.1002/advs.202409854 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2025. Verfasst von Chuyao Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medic…. Hauptthemen laut MEDLINE: Retina, Retinal Diseases, Nerve Regeneration, Nanotechnology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Capital Health Research and Development of Special, Science & Technology Project of Beijing Municipal Science & Technology Commission.
Abstract (Originalsprache)
Retinal diseases can severely impair vision and even lead to blindness, posing significant threats to both physical and mental health. Physical retinal regenerative therapies are poised to revolutionize the treatment of various disorders associated with blindness. However, these therapies must overcome the challenges posed by the protective inner and outer blood‒retinal barriers. Nanotechnology applications in ophthalmology have shown great potential in addressing the issue of drug delivery to the eye. Moreover, nanotechnology‐based therapeutics can have profound clinical impacts on retinopathy, particularly retinal regeneration, thereby improving patient outcomes. Continuous advancements in nanotechnology are being applied to regenerate lost or damaged eye tissues and to treat vision loss and blindness caused by various retinal degenerative diseases. These approaches can be categorized into three main strategies: i) nanoparticles for delivering drugs, genes, and other essential substances; ii) nanoscaffolds for providing biocompatible support; and iii) nanocomposites for enhancing the functionality of primary or stem cells. The aim of this comprehensive review is to present the current understanding of nanotechnology‐based therapeutics for retinal regeneration, with a focus on the perspective functions of nanomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of…
- Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, 101400, China.
ORCID-Profile: Dan Luo
Förderung
- National Natural Science Foundation of China
- The Capital Health Research and Development of Special
- Science & Technology Project of Beijing Municipal Science & Technology Commission
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- R&D Program of Beijing Municipal Education Commission
- The priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University
Zitieren
APA
Yu, C., Dong, L., Lv, Y., Shi, X., Zhang, R., Zhou, W., Wu, H., Li, H., Li, Y., Li, Z., Luo, D., & Wei, W. B. (2025). Nanotherapy for Neural Retinal Regeneration. Advanced Science. https://doi.org/10.1002/advs.202409854
Vancouver
Yu C, Dong L, Lv Y, Shi X, Zhang R, Zhou W, et al. Nanotherapy for Neural Retinal Regeneration. Advanced Science. 2025. doi:10.1002/advs.202409854
BibTeX
@article{Yu2025,
author = {Yu, Chuyao and Dong, Li and Lv, Yujia and Shi, Xuhan and Zhang, Ruiheng and Zhou, Wenda and Wu, Haotian and Li, Heyan and Li, Yitong and Li, Zhou and Luo, Dan and Wei, Wen-Bin},
title = {Nanotherapy for Neural Retinal Regeneration},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409854}
}
EUVIMED